Latest filing published 23 Jun 2025 for Zai Lab Ltd.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -7.5%Entry US$246.92 · Close at T+365 US$228.52
- +28.3%Entry US$231.18 · Close at T+365 US$296.52
- -9.7%Entry US$339.85 · Close at T+365 US$307.00
- -1.8%Entry US$271.36 · Close at T+365 US$266.44
- -2.3%Entry US$293.59 · Close at T+365 US$286.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michel Vounatsos: trading record in brief
Filings by Michel Vounatsos span 3 companies, the busiest being Biogen Inc., Revvity, Inc. and Zai Lab Ltd. The record holds 57 filings, for trades running from 27 February 2017 to 18 June 2025.
On the market, this insider has only ever bought: 5 purchases, €2.4M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 37 share grants and 15 option exercises.
In size, the median ticket on the buying side is €360k. On 3 out of 5 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +5.1%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 23 June 2025, reports a share grant in Zai Lab Ltd. The last insider purchase was made public on 1 December 2020, 2,168 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michel Vounatsos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,831 shares0American Depositary SharesSEC:0000905148-25-002220:0
- 1,338 shares0Common StockSEC:0000950170-25-061826:1
- 1,074 shares0Common StockSEC:0000950170-25-061826:0
- 21,253 shares0American Depositary SharesSEC:0000905148-24-001751:0
- 1,218 shares0Common StockSEC:0000950170-24-052069:1
- 977 shares0Common StockSEC:0000950170-24-052069:0
- 955 shares0Common StockSEC:0000950170-23-022714:1
- 783 shares0Common StockSEC:0000950170-23-022714:0
- 18,332 shares0American Depositary SharesSEC:0000899243-23-007332:0
- 744 shares0Common StockSEC:0000899243-22-017248:1
- 610 shares0Common StockSEC:0000899243-22-017248:0
- 2,746 shares@ US$209.794.1% of flowCommon StockSEC:0001127602-22-006280:1
- 6,191 shares0Common StockSEC:0001127602-22-006280:0
- 1,917 shares@ US$214.592.9% of flowCommon StockSEC:0001127602-22-004986:1
- 1,950 shares@ US$214.593.0% of flowCommon StockSEC:0001127602-22-004986:3
- 4,699 shares@ US$214.597.1% of flowCommon StockSEC:0001127602-22-004986:4
- 4,395 shares0Common StockSEC:0001127602-22-004986:2
- 4,321 shares0Common StockSEC:0001127602-22-004986:0
- 10,594 shares0Common StockSEC:0001127602-22-001859:0
- 709 shares0Common StockSEC:0000899243-21-018993:1
- 604 shares0Common StockSEC:0000899243-21-018993:0
- 7,248 shares@ US$278.0316.2% of flowCommon StockSEC:0001127602-21-006281:0
- 2,525 shares@ US$278.035.7% of flowCommon StockSEC:0001127602-21-006281:4
- 2,333 shares@ US$278.035.2% of flowCommon StockSEC:0001127602-21-006281:5
- 2,367 shares@ US$278.035.3% of flowCommon StockSEC:0001127602-21-006281:6
25 of 57 declarations
